Menu Close
Manifestation Man Graphic

COSENTYX targets more than joint pain. It treats the multiple symptoms of psoriatic arthritis (PsA), like joint pain and tenderness† and back pain.‡ It also helps clear skin, and helps stop further joint damage.§

†In a clinical trial of adults taking 300 mg at 16 weeks.

‡In a clinical trial of adults taking COSENTYX 300 mg as their first biologic at 12 weeks.

§Based on data from X-rays of the hands and feet at 6 months.

COSENTYX WORKS FAST FOR RESULTS THAT CAN LAST

3 WKS

COSENTYX can start working in as little as 3 weeks.

Up to 60% of adults taking COSENTYX 150 mg in a clinical trial saw at least a 20% improvement in PsA symptoms at 16 weeks versus 18% of adults taking placebo.

5 YRS

COSENTYX has been proven to last.

For adults who continued on COSENTYX for 5 years, a similar percentage saw an improvement in PsA symptoms. In this study, the medication being used was revealed to doctors and adults after 1 year, which may affect the results.

"I realized COSENTYX was working for me when I was missing out on less and less."

Jordan’s psoriasis and psoriatic arthritis felt like a “coordinated attack” for years before she found real relief with COSENTYX.

Watch as she moves on from her symptoms while moving into her new home.

Jordan is an actual patient and was compensated for her time.

Select each of the photos below to see how COSENTYX helps you take on your daily activities so you can move forward.

At 16 weeks, adults in clinical trials completed a questionnaire that asked how difficult it was to complete daily activities. On average at 16 weeks, adults taking COSENTYX showed overall improvement in their ability to perform daily activities. The questions covered categories such as:

Thumbnail
Getting in and out of bed

Getting in and out of bed

Thumbnail
Getting dressed on their own

Getting dressed on their own

Thumbnail
Using hands to eat

Using hands to eat

Thumbnail
Reaching

Reaching

Thumbnail
Gripping objects

Gripping objects

Thumbnail
Walking

Walking

Taking care of personal hygiene
Taking care of personal hygiene

Taking care of personal hygiene

Real Talk with Dr. Elizabeth Perkins

See how real people taking COSENTYX are feeling since starting treatment in this Real Talk series of doctor--patient conversations.

Dr. Perkins was compensated for her time.

Learn More

Watch Real Stories

See how real people taking COSENTYX are feeling since starting treatment.

WATCH ME MOVE ON: TINA

After finding real relief from her psoriatic arthritis symptoms with COSENTYX, Tina and her family are back to going places and spending more time together. Watch their story.

Actual COSENTYX patients, compensated for their time.

5/22 207490

View more
View less
Indications

COSENTYX® (secukinumab) is a prescription medicine used to treat:

  • people 6 years of age and older with moderate to severe plaque psoriasis that involves large areas or many areas of the body, and who may benefit from taking injections or pills (systemic therapy) or phototherapy (treatment using ultraviolet or UV light alone or with systemic therapy)

  • people 4 years of age and older with active enthesitis-related arthritis

  • people 2 years of age and older with active psoriatic arthritis

  • adults with active ankylosing spondylitis

  • adults with active non-radiographic axial spondyloarthritis and objective signs of inflammation

Important Safety Information

Do not use COSENTYX if you have had a severe allergic reaction to secukinumab or any of the other ingredients in COSENTYX. See the Medication Guide for a complete list of ingredients.

COSENTYX is a medicine that affects your immune system. COSENTYX may increase your risk of having serious side effects such as:

Infections

COSENTYX may lower the ability of your immune system to fight infections and may increase your risk of infections, sometimes serious.

  • Your doctor should check you for tuberculosis (TB) before starting treatment with COSENTYX.
  • If your doctor feels that you are at risk for TB, you may be treated with medicine for TB before you begin treatment with COSENTYX and during treatment with COSENTYX.
  • Your doctor should watch you closely for signs and symptoms of TB during treatment with COSENTYX. Do not take COSENTYX if you have an active TB infection.

Before starting COSENTYX, tell your doctor if you:

  • are being treated for an infection
  • have an infection that does not go away or that keeps coming back
  • have TB or have been in close contact with someone with TB
  • think you have an infection or have symptoms of an infection such as: fevers, sweats, or chills; muscle aches; cough; shortness of breath; blood in your phlegm; weight loss; warm, red, or painful skin or sores on your body; diarrhea or stomach pain; burning when you urinate or urinate more often than normal

After starting COSENTYX, call your doctor right away if you have any signs of infection listed above. Do not use COSENTYX if you have any signs of infection unless you are instructed to by your doctor.

Inflammatory bowel disease

New cases of inflammatory bowel disease or “flare-ups” can happen with COSENTYX, and can sometimes be serious. If you have inflammatory bowel disease (ulcerative colitis or Crohn’s disease), tell your doctor if you have worsening disease symptoms during treatment with COSENTYX or develop new symptoms of stomach pain or diarrhea.

Serious allergic reactions

Serious allergic reactions can occur. Get emergency medical help right away if you get any of the following symptoms: feeling faint; swelling of your face, eyelids, lips, mouth, tongue, or throat; trouble breathing or throat tightness; chest tightness; skin rash or hives (red, itchy bumps). If you have a severe allergic reaction, do not give another injection of COSENTYX.  

Before starting COSENTYX, tell your doctor if you:

  • have any of the conditions or symptoms listed above for infections.

  • have inflammatory bowel disease (Crohn's disease or ulcerative colitis).

  • are allergic to latex. The needle cap on the COSENTYX Sensoready® 150 mg/mL pen and the 150 mg/mL and 75 mg/0.5 mL prefilled syringes contains latex.

  • have recently received or are scheduled to receive an immunization (vaccine). People who take COSENTYX should not receive live vaccines. Children should be brought up to date with all vaccines before starting COSENTYX.

  • have any other medical conditions.

  • are pregnant or plan to become pregnant. It is not known if COSENTYX can harm your unborn baby. You and your doctor should decide if you will use COSENTYX.

  • are breastfeeding or plan to breastfeed. It is not known if COSENTYX passes into your breast milk.

Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Know the medicines you take. Keep a list of your medicines to show your doctor and pharmacist when you get a new medicine.

How should I use COSENTYX?

See the detailed Instructions for Use that comes with your COSENTYX for information on how to prepare and inject a dose of COSENTYX, and how to properly throw away (dispose of) used COSENTYX Sensoready pens and prefilled syringes.

  • Use COSENTYX exactly as prescribed by your doctor.

  • If your doctor decides that you or a caregiver may give your injections of COSENTYX at home, you should receive training on the right way to prepare and inject COSENTYX. Do not try to inject COSENTYX yourself, until you or your caregiver has been shown how to inject COSENTYX by your doctor or nurse.

The most common side effects of COSENTYX include: cold symptoms, diarrhea, and upper respiratory infections. These are not all of the possible side effects of COSENTYX. Call your doctor for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

 Please see full Prescribing Information, including Medication Guide.

 

 

 

*Limitations apply. Up to a $16,000 annual limit. Offer not valid under Medicare, Medicaid, or any other federal or state program. Novartis reserves the right to rescind, revoke, or amend this program without notice. See complete Terms & Conditions for details.

Use of website is governed by the Terms of Use and Privacy Statement.

Copyright © 2022 Novartis Pharmaceuticals Corporation. All rights reserved.

6/22 212097